Summary
Since the withdrawal of phenformin in 1978, the use of metformin has increased from 13,500 to 22,00 patient years/year. During the period 1977–91 a total of 18 cases of metformin — associated acidosis was reported, of which 16 had lactic acidosis.
The incidence of reported acidosis and lactic acidosis decreased from 1.50 cases per 10,000 patient years in 1977–81 to 0.24 cases per 10,000 patient years 1987–91, probably due to lower doses doses and reduced usage in the very old. All the reports described patients with several other concomitant diseases, mainly cardiovascular and renal, when the acidosis was diagnosed.
It is important continuously to re-evaluate metformin therapy and to stop treatment at the onset of impaired renal or cardiovascular function.
References
Hermann LS, melander A (1992) Biguanides: basic aspects and clinical uses. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) Textbook of Diabetes Mellitus. Wiley, New York Chichester, pp 773–795
Vigneri R, Goldfine I (1987) Role of metformin in treatment of diabetes mellitus. Diabetes Care 10: 118–122
Bergman U, Boman G, Wiholm B-E (1978) Epidemiology of adverse drug reactions to phenformin and metformin. BMJ 2: 464–466
Wiholm B-E (1983) Spontaneous reporting of ADR. Fertilization with register data on morbidity and drug utilization. In: Skandia International Symposia, Stockholm
Myrhed M (1989) Drug induced morbidity. The size of the problem and possible strategies for intervention. Symposium arranged by the Swedish Drug Insurance Association, Stockholm
Nordic Statistics of Medicines 1975–1977 (1979) Part I. Nordic Council on Medicines, Uppsala
Svensk Läkemedelsstatistik (1988) Apoteksbolaget, Stockholm
Karam JH, Matin SB, Forsham PH (1975) Antidiabetic drugs after the University Group Diabetes Program (UGDP). Ann Rev Pharmacol 15: 351–366
Czyzyk A, Tawecki J, Sadowski J, Ponikowska I, Szczepanik Z (1986) Effect of biguanides on intestinal absorption of glucose. Diabetes 17: 492–498
Searle GL, Gulli R (1980) The mechanism of the acute hypoglycemic action of phenformin (DMI). Metabolism 29: 630–635
Hermann LS (1973) Biguanides and lactate metabolism: a review. Dan Med Bull 20: 65–79
Luft D, Schmulling RM, Eggstein M (1978) Lactic acidosis in biguanide-treated diabetics. Diabetologia 14: 75–87
Shah RR, Oates NS, Idle JR, Smith RL (1980) Genetic impairment of phenformin metabolism. Lancet II: 1147
Wiholm B-E, Alván G, Bertilsson L, Säwe J, Sjöqvist F (1981) Hydroxylation of debrisoquine in patients with lactic acidosis after phenformin. Lancet I: 1099
Campbell IW (1984) Metformin and glibenclamide comparative risks. BMJ 289: 289
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wiholm, B.E., Myrhed, M. Metformin-associated lactic acidosis in Sweden 1977–1991. Eur J Clin Pharmacol 44, 589–591 (1993). https://doi.org/10.1007/BF02440866
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02440866